FDA Peptide Reclassification 2026: What It Means for Providers BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Why Are People Injecting Themselves with Peptides? The New Yorker Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The Emerging Risk of Peptides in Supplements LegitScript